2,3-bis(4-hydroxyphenyl)-propionitrile has been researched along with Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dertsiz, EK; Ercan, F; Koyuncuoğlu, T; Yeğen, BÇ; Yıldırım, A; Yüksel, M | 1 |
| Bozkus, F; Kurt, AH; Uremis, MM; Uremis, N | 1 |
2 other study(ies) available for 2,3-bis(4-hydroxyphenyl)-propionitrile and Kidney Diseases
| Article | Year |
|---|---|
Estrogen receptor agonists protect against acetaminophen-induced hepatorenal toxicity in rats.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Antioxidants; Chemical and Drug Induced Liver Injury; Estradiol; Estrogens; Female; Glutathione; Kidney Diseases; Male; Nitriles; Oxidative Stress; Propionates; Protective Agents; Rats; Rats, Sprague-Dawley; Receptors, Estrogen | 2020 |
The protective role of G protein-coupled estrogen receptor 1 (GPER-1) on methotrexate-induced nephrotoxicity in human renal epithelium cells.
Topics: Antimetabolites, Antineoplastic; Cells, Cultured; Epithelial Cells; Estradiol; Humans; Kidney Diseases; Kidney Tubules, Proximal; Methotrexate; Nitriles; Phenols; Propionates; Protective Agents; Pyrazoles; Receptors, Estrogen | 2016 |